Guidance
V3P: Key Findings for Rota
The Vaccine Product Price & Procurement (V3P) initiative was launched to provide all countries with a platform for greater vaccine price & procurement transparency. The initiative collects data through the WHO and UNICEF Joint Reporting Form, analyses and distributes information to relevant stakeholders to inform policy making and procurement processes. As of July 2017, the database contained data from 144 countries.
The fact sheet is exclusively based on the data reported through the JRF & V3P initiative, as of July 2017.
Authors
Languages
- English
Publication year
2018
Publisher
WHO
Type
Guidance
Categories
- Programme management
Diseases
- Rotavirus
Organisations
- World Health Organisation (WHO)
Tags
- MI4A
Topic references
MARKET_STUDIES
| Title | Author | Year | Type | Language |
|---|---|---|---|---|
| Global Market Study: BCG Vaccine - May 2019 | World Health Organization (WHO) | 2019 | Report | English |
| Global Market Study: Diphtheria and tetanus-containing vaccines - 2019 | World Health Organization (WHO) | 2019 | Report | English |
| Global Market Study: Hepatitis A virus - 2023 | World Health Organization (WHO) | 2023 | Report | English |
| Global Market Study: HPV vaccines - 2019 | World Health Organization (WHO) | 2019 | Report | English |
| Global Market Study: Meningococcal meningitis vaccines - 2019 | World Health Organization (WHO) | 2019 | Report | English |
| Global Vaccine Market Report - 2019 | World Health Organization (WHO) | 2019 | Report | English |
| V3P: Key Findings for Rota | World Health Organization (WHO) | 2018 | Guidance | English |
